TickerFacts.

Zai Lab Ltd (ZLAB): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$150.79M
Year ended 2025-12-31
-$133.38M
Trailing 12 months to 2026-06-30
2015-12-31: -$11.46M2016-12-31: -$32.16M2017-12-31: -$32.37M2018-12-31: -$97.54M2019-12-31: -$191.01M2020-12-31: -$216.06M2021-12-31: -$549.23M2022-12-31: -$367.64M2023-12-31: -$198.18M2024-12-31: -$214.87M2025-12-31: -$150.79M-$150.79M
2015-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$150.79Mn/m2026-02-26, From 2025-01-01
2024-12-31-$214.87Mn/m2026-02-26, From 2024-01-01
2023-12-31-$198.18Mn/m2026-02-26, From 2023-01-01
2022-12-31-$367.64Mn/m2025-02-27, From 2022-01-01
2021-12-31-$549.23Mn/m2024-02-27, From 2021-01-01
2020-12-31-$216.06Mn/m2023-03-01, From 2020-01-01
2019-12-31-$191.01Mn/m2022-03-01, From 2019-01-01
2018-12-31-$97.54Mn/m2021-03-01, From 2018-01-01
2017-12-31-$32.37Mn/m2020-04-29, From 2017-01-01
2016-12-31-$32.16Mn/m2019-03-29, From 2016-01-01
2015-12-31-$11.46Mn/a2018-04-30, From 2015-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Zai Lab Ltd (ZLAB)2025-12-31-$150.79Mn/m
Nature's Sunshine Products Inc (NATR)2025-12-31$35.32M+39.6%
Travere Therapeutics, Inc. (TVTX)2025-12-31$37.78Mn/m
BridgeBio Pharma, Inc. (BBIO)2025-12-31-$445.91Mn/m
Innoviva, Inc. (INVA)2025-12-31$196.93M+4.4%
Ardelyx, Inc. (ARDX)2025-12-31-$42.48Mn/m
Mirum Pharmaceuticals, Inc. (MIRM)2025-12-31$55.83M+440.7%
Sinovac Biotech Ltd (SVA)2025-12-31-$512.18Mn/m
HUTCHMED (China) Ltd (HCM)2025-12-31-$64.66Mn/m

Compare ZLAB, NATR, TVTX, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗